YourChoice Therapeutics begins first-in-human trial for male birth control pill

Contributed by: Business Wire

Tags

Biotechnology

Pharmaceutical

Men

Health

Baby/Maternity

Consumer

Clinical Trials

Other Health

male birth control pill

More Like This

YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill

Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

PR Newswire associated0

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

PR Newswire associated0

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia